Record #47470
Efficacy, Safety, and Impact on Patient Survival of PDL1/PD-1 Inhibitors versus FOLFIRINOX Regimens for Advanced Pancreatic Cancer
Publisher
Original paper date
Jun 18, 2022
Original DOI
Country
Institution
Nanjing University of Chinese Medicine, Nanjing, 210023 Jiangsu Province, China · Department of General Surgery, Nanjing Hospital of Chinese Medicine Nanjing, 210012 Jiangsu Province, China · Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University, Nanjing, 210008 Jiangsu Province, China
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
1
Post-retraction
0
% post-retraction
0.0%
~0.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…